期刊文献+

C反应蛋白与冠状动脉粥样硬化性心脏病 被引量:14

C-reactive Protein and Coronary Atherosclerotic Heart Disease
下载PDF
导出
摘要 冠状动脉粥样硬化性心脏病中炎症扮演了重要的角色,而炎症的重要标记物C反应蛋白与冠心病的关系正逐渐成为研究的热潮。现综述C反应蛋白的来源、特性、代谢等问题,并通过临床试验、药物试验、细胞分子水平实验及动物实验几个方面的论述来认识C反应蛋白与冠心病的关系,试图了解目前的证据能支持C反应蛋白在冠状动脉疾病发生发展中所起的作用。 Inflammation plays an important role in coronary atherosclerotic heart disease ( CAHD ). C-reactive protein ( CRP ) is one of the important markers of inflammation in vivo. Research into the relationship between CRP and CAHD is becoming popular. This review analyses the relationship by examining the latest evidence published by international scholars. High levels of CRP level are related to high risk of coronary events,but are not necessarily a causal relationship.
作者 刘萍萍 张健
出处 《心血管病学进展》 CAS 2007年第2期212-214,共3页 Advances in Cardiovascular Diseases
关键词 C反应蛋白 冠状动脉粥样硬化性心脏病 HMG-COA还原酶抑制剂 C-reactive protein coronary atherosclerotic heart diseases hydroxymethytglutaryl-CoA reductase inhibitors
  • 相关文献

参考文献18

  • 1Pepys MB,Hirschfield GM.C-reactive protein:A critical update[J].J Clin Invest,2003,111:1805-1812.
  • 2Thompson SG,Kienast J,Pyke SDM,et al.Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris[J].N Engl J Med,1995,332:635-641.
  • 3Calabro P,Willerson JT,Yeh ET.Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells[J].Circulation,2003,108:1930-1932.
  • 4Calabro P,Chang D,Willerson JT,et al.Release of C-reactive protein in re-sponse to inflammatory cytokines by human adipocytes[J].J Am Coll Cardiol,2005,46:1112-1113.
  • 5Schwedler SB,Amann K,Wernicke K,et al.Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice[J].Circulation,2005,112:1016-1023.
  • 6Ridker PM,Rifai N,Clearfield M,et al.Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators.Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events[J].N Engl J Med,2001,344(26):1959-1965.
  • 7Ridker PM,Cannon CP,Morrow D,et al.Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators.C-reactive protein levels and outcomes after statin therapy[J].N Engl J Med,2005,352(1):20-28.
  • 8Nissen SE,Tuzcu EM,Schoenhagen P,et al.Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators.Statin therapy,LDL cholesterol,C-reactive protein,and coronary artery disease[J].N Engl J Med,2005,352(1):29-38.
  • 9Nissen SE,Tuzcu EM,Schoenhagen P,et al.REVERSAL Investigators.Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis:A randomized controlled trial[J].JAMA,2004,291(9):1071-1080.
  • 10Taylor KE,Giddings JC,van den Berg CW.C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide[J].Arterioscler Thromb Vasc Biol,2005,25:1225-1230.

同被引文献146

引证文献14

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部